AAAAAA

   
Results: 1-11 |
Results: 11
Synthesis of ethyl alkylidene alpha cyanoacetates under ultrasound irradiation
Authors: Li, JT Zang, HJ Meng, LH Li, LJ Yin, YH Li, TS
Citation: Jt. Li et al., Synthesis of ethyl alkylidene alpha cyanoacetates under ultrasound irradiation, ULTRASON SO, 8(2), 2001, pp. 93-95
DNA topoisomerase II as primary cellular target for salvicine in Saccharomyces cerevisiae
Authors: Meng, LH He, XX Zhang, JS Ding, J
Citation: Lh. Meng et al., DNA topoisomerase II as primary cellular target for salvicine in Saccharomyces cerevisiae, ACT PHAR SI, 22(8), 2001, pp. 741-746
Cytotoxic oxoisoaporphine alkaloids from Menispermum dauricum
Authors: Yu, BW Meng, LH Chen, JY Zhou, TX Cheng, KF Ding, J Qin, GW
Citation: Bw. Yu et al., Cytotoxic oxoisoaporphine alkaloids from Menispermum dauricum, J NAT PROD, 64(7), 2001, pp. 968-970
Induction of bulk and c-myc P2 promoter-specific DNA damage by an anti-topoisomerase II agent salvicine is an early event leading to apoptosis in HL-60 cells
Authors: Meng, LH Ding, J
Citation: Lh. Meng et J. Ding, Induction of bulk and c-myc P2 promoter-specific DNA damage by an anti-topoisomerase II agent salvicine is an early event leading to apoptosis in HL-60 cells, FEBS LETTER, 501(1), 2001, pp. 59-64
Salvicine, a novel DNA topoisomerase II inhibitor, exerting its effects bytrapping enzyme-DNA cleavage complexes
Authors: Meng, LH Zhang, JS Ding, J
Citation: Lh. Meng et al., Salvicine, a novel DNA topoisomerase II inhibitor, exerting its effects bytrapping enzyme-DNA cleavage complexes, BIOCH PHARM, 62(6), 2001, pp. 733-741
New tetraazamacrocyclic ligand with neutral pendent groups 1,4,7,10-tetrakis(2-cyanoethyl)-1,4,7,10-tetraazacyclododecane (L) and its cobalt(II), nickel(II) and copper(II) complexes: synthesis, structural characterization and antitumor activity
Authors: Kong, DY Meng, LH Ding, J Xie, YY Huang, XY
Citation: Dy. Kong et al., New tetraazamacrocyclic ligand with neutral pendent groups 1,4,7,10-tetrakis(2-cyanoethyl)-1,4,7,10-tetraazacyclododecane (L) and its cobalt(II), nickel(II) and copper(II) complexes: synthesis, structural characterization and antitumor activity, POLYHEDRON, 19(2), 2000, pp. 217-223
Synthesis, structural characterization and antitumor activity evaluations of copper complex with tetraazamacrocyclic ligand
Authors: Kong, DY Qin, C Meng, LH Xie, YY
Citation: Dy. Kong et al., Synthesis, structural characterization and antitumor activity evaluations of copper complex with tetraazamacrocyclic ligand, BIOORG MED, 9(8), 1999, pp. 1087-1092
Total synthesis of the potent proteasome inhibitor epoxomicin: A useful tool for understanding proteasome biology
Authors: Sin, N Kim, KB Elofsson, M Meng, LH Auth, H Kwok, BHB Crews, CM
Citation: N. Sin et al., Total synthesis of the potent proteasome inhibitor epoxomicin: A useful tool for understanding proteasome biology, BIOORG MED, 9(15), 1999, pp. 2283-2288
Synthesis, structure and antitumor activities of a new macrocyclic ligand with four neutral pendent groups: 1,4,7,10-tetrakisbenzyl-1,4,7,10-tetraazacyclododecane (L) and its Co, Ni and Cu complexes
Authors: Kong, DY Meng, LH Song, L Xie, YY
Citation: Dy. Kong et al., Synthesis, structure and antitumor activities of a new macrocyclic ligand with four neutral pendent groups: 1,4,7,10-tetrakisbenzyl-1,4,7,10-tetraazacyclododecane (L) and its Co, Ni and Cu complexes, TRANSIT MET, 24(5), 1999, pp. 553-557
Epoxomicin, a potent and selective proteasome inhibitor, exhibits in vivo antiinflammatory activity
Authors: Meng, LH Mohan, R Kwok, BHB Elofsson, M Sin, N Crews, CM
Citation: Lh. Meng et al., Epoxomicin, a potent and selective proteasome inhibitor, exhibits in vivo antiinflammatory activity, P NAS US, 96(18), 1999, pp. 10403-10408
Eponemycin exerts its autitumor effect through the inhibition of proteasome function
Authors: Meng, LH Kwok, BHB Sin, N Crews, CM
Citation: Lh. Meng et al., Eponemycin exerts its autitumor effect through the inhibition of proteasome function, CANCER RES, 59(12), 1999, pp. 2798-2801
Risultati: 1-11 |